Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines.
Bergman
A M
AM
Dept. Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.
Ruiz van Haperen
V W
VW
Veerman
G
G
Kuiper
C M
CM
Peters
G J
GJ
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002945:Cisplatin / Q000633:toxicity*; D003110:Colonic Neoplasms; D003564:Cytidine Deaminase; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000633:toxicity; D003842:Deoxycytidine Kinase / Q000378:metabolism; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007700:Kinetics; D051379:Mice; D009700:Nucleoside Deaminases / Q000378:metabolism; D010051:Ovarian Neoplasms; D013997:Time Factors; D014407:Tumor Cells, Cultured; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D003842:Deoxycytidine Kinase; D009700:Nucleoside Deaminases; D003564:Cytidine Deaminase; C011530:deoxycytidine deaminase; D002945:Cisplatin; D000093542:Gemcitabine